Home
/
Treatment
/
DCVAC OvCa

DCVAC OvCa

February 8, 2015[email protected]

	DCVAC OvCa
Trade Name
Orphan Indication	Ovarian cancer
USA Market Approval	USA
USA Designation Date	2013-05-14 00:00:00
Sponsor	SOTIOS a.s.;Jankovcova 1518/2, 170 00 Praha 7;

Related Access Program

AstraZeneca – PSR Ovarian Cancer With a BRCA Mutation Tesaro, Inc. – Recurrent Ovarian Cancer AstraZeneca – Ovarian Cancer